W celu świadczenia usług na najwyższym poziomie stosujemy pliki cookies. Korzystanie z naszej witryny oznacza, że będą one zamieszczane w Państwa urządzeniu. W każdym momencie można dokonać zmiany ustawień Państwa przeglądarki. Zobacz politykę Cookies
X

Transparency Council

The Meeting of the Transparency Council No. 34/2022 of 29.08.2022

more...

The Meeting of the Transparency Council No. 33/2022 of 22.08.2022

more...

Opinion of the Transparency Council – health policy programme on thyroid diseases (Town of Leszno)

more...

Opinion of the Transparency Council – health policy programme on infertility treatment (Rzeszów)

more...

Opinion of the Transparency Council – health policy programme on breast cancer (Municipality of Toszek)

more...

Position of the Transparency Council – Inovelon (rufinamide)

more...

Position of the Transparency Council – Fycompa (perampanel)

more...

Opinion of the Transparency Council – changes to the drug programme B.82

more...

Opinion of the Transparency Council – active substance etanercept

more...

Opinion of the Transparency Council – changes to the drug programme B.44

more...

Position of the Transparency Council – Ozurdex (dexamethasone)

more...

Position of the Transparency Council – Tremfya (guselkumab)

more...

Position of the Transparency Council – Suliqua (insulinum glarginum + lixisenatidum)

more...

Position of the Transparency Council – Onureg (azacitidine)

more...

The Meeting of the Transparency Council No. 32/2022 of 16.08.2022

more...

The Meeting of the Transparency Council No. 31/2022 of 11.08.2022

more...

The Meeting of the Transparency Council No. 30/2022 of 01.08.2022.

more...

Opinion of the Transparency Council – health policy programme on therapeutic rehabilitation (town of Żyrardów)

more...

Opinion of the Transparency Council – health policy programme on breast cancer prevention (town of Sieradz)

more...

Opinion of the Transparency Council – changes to the drug programme B.61

more...

Opinion of the Transparency Council – active substance ipratropii bromidum

more...

Opinion of the Transparency Council – active substances fenoteroli hydrobromidum + ipratropii bromidum

more...

Opinion of the Transparency Council – active substance prednisone

more...

Opinion of the Transparency Council – active substances amiloridum + hydrochlorothiazidum

more...